Cierra Melone, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6344 Transit Rd, Depew, NY 14043 Phone: 716-683-9444 |
Cindy Susan Kostek, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4937 Transit Rd, Depew, NY 14043 Phone: 716-685-1729 Fax: 716-685-3309 |
Suzanne M Welninski Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 578 Dick Rd, Depew, NY 14043 Phone: 716-683-9870 |
Miss Jacqueline Ann Cansdale Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4920 Transit Rd, T2191, Depew, NY 14043 Phone: 716-608-2021 Fax: 716-608-2021 |
Mary Ellen Riga, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 651 Dick Rd, Depew, NY 14043 Phone: 716-681-2715 Fax: 716-686-0630 |
Jamie R Miranda, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 651 Dick Rd, Depew, NY 14043 Phone: 716-681-2715 Fax: 716-686-0630 |
Kathleen Elaine Rojek, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5175 Broadway, Depew, NY 14043 Phone: 716-515-3435 Fax: 716-515-1101 |
Alicia Oehler Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4777 Transit Rd, Depew, NY 14043 Phone: 716-515-3290 |
Brian Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 651 Dick Rd, Depew, NY 14043 Phone: 716-681-2715 Fax: 585-686-0630 |
Katie Lyn Marcheson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4777 Transit Rd, Depew, NY 14043 Phone: 716-515-3290 |
Peter Vanhouten, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 578 Dick Rd, Depew, NY 14043 Phone: 716-683-9870 |
Mr. Brian J Brady, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 578 Dick Rd, Depew, NY 14043 Phone: 716-683-9870 |
Mrs. Jane C Ringle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 Christophel Dr, Depew, NY 14043 Phone: 716-685-5690 |
Dr. Kairi Stockwell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 124 Taylor Dr, Depew, NY 14043 Phone: 716-635-5276 Fax: 716-635-5991 |
Mr. Paul Henry Bembenista, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 6350 Transit Rd, Depew, NY 14043 Phone: 716-706-2326 |
Terri A Pierino, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4777 Transit Rd, Depew, NY 14043 Phone: 716-515-3290 Fax: 855-331-9020 |
Mrs. Lucy Anne Grad, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4777 Transit Rd, Depew, NY 14043 Phone: 716-515-3290 Fax: 716-515-3294 |
Dr. Raymond Burgess, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 124 Taylor Dr, Depew, NY 14043 Phone: 716-635-5276 Fax: 716-635-5991 |
Ellen Geiter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4960 Transit Rd, Depew, NY 14043 Phone: 716-685-7310 Fax: 716-685-7325 |
Jeremy Partlow, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4815 Broadway, Depew, NY 14043 Phone: 716-683-7971 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
Alzheimer's disease can be devastating to families who become caregivers. Anyone seeking more information about Alzheimer's is invited to attend the Alzheimer's Association's "Care to Cure: the latest in research and care giving" conference on Saturday, May 22 in Concord.
Current public health guidelines recommend that only gay men and people with HIV should be routinely screened for extragenital gonorrhea and chlamydia, given the high burden of these sexually transmitted infections (STIs) in this at-risk population.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago